1. Home
  2. MRKR vs LINK Comparison

MRKR vs LINK Comparison

Compare MRKR & LINK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRKR
  • LINK
  • Stock Information
  • Founded
  • MRKR N/A
  • LINK 1984
  • Country
  • MRKR United States
  • LINK United States
  • Employees
  • MRKR N/A
  • LINK N/A
  • Industry
  • MRKR Biotechnology: Pharmaceutical Preparations
  • LINK Industrial Machinery/Components
  • Sector
  • MRKR Health Care
  • LINK Technology
  • Exchange
  • MRKR Nasdaq
  • LINK Nasdaq
  • Market Cap
  • MRKR 35.8M
  • LINK 34.1M
  • IPO Year
  • MRKR N/A
  • LINK N/A
  • Fundamental
  • Price
  • MRKR $3.10
  • LINK $4.55
  • Analyst Decision
  • MRKR Strong Buy
  • LINK
  • Analyst Count
  • MRKR 1
  • LINK 0
  • Target Price
  • MRKR $19.00
  • LINK N/A
  • AVG Volume (30 Days)
  • MRKR 26.1K
  • LINK 37.6K
  • Earning Date
  • MRKR 11-14-2024
  • LINK 11-07-2024
  • Dividend Yield
  • MRKR N/A
  • LINK N/A
  • EPS Growth
  • MRKR N/A
  • LINK N/A
  • EPS
  • MRKR N/A
  • LINK N/A
  • Revenue
  • MRKR $5,395,849.00
  • LINK $12,231,000.00
  • Revenue This Year
  • MRKR $35.94
  • LINK N/A
  • Revenue Next Year
  • MRKR N/A
  • LINK $11.48
  • P/E Ratio
  • MRKR N/A
  • LINK N/A
  • Revenue Growth
  • MRKR 79.04
  • LINK 1.81
  • 52 Week Low
  • MRKR $2.44
  • LINK $3.25
  • 52 Week High
  • MRKR $6.16
  • LINK $9.33
  • Technical
  • Relative Strength Index (RSI)
  • MRKR 42.91
  • LINK 45.57
  • Support Level
  • MRKR $2.91
  • LINK $4.79
  • Resistance Level
  • MRKR $3.25
  • LINK $5.51
  • Average True Range (ATR)
  • MRKR 0.38
  • LINK 0.56
  • MACD
  • MRKR -0.11
  • LINK -0.13
  • Stochastic Oscillator
  • MRKR 17.72
  • LINK 9.26

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.

About LINK Interlink Electronics Inc.

Interlink Electronics Inc is a global sensor and printed electronics company operating in two principal sensor technology divisions: force/touch sensors, and gas and environmental sensors. It designs, develops, manufactures and sells a range of force-sensing and gas-sensing technologies that incorporate its proprietary materials technology, firmware and software into a portfolio of standard sensor-based products and custom sensor system solutions. Its force-sensing products and solutions include sensor components, subassemblies, modules products that support effective, efficient cursor control and novel three-dimensional user inputs. Its Human Machine Interface technology platforms are deployed in a wide range of markets including consumer electronics, automotive, industrial, and medical.

Share on Social Networks: